• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Emergency

Young adult patients recovering from COVID-19 might be at increased risk of acute ischemic stroke

byJake EngelandMichael Pratte
June 2, 2021
in Emergency, Infectious Disease, Neurology, Public Health
Reading Time: 2 mins read
Intensive rehabilitation not superior to traditional therapy for arm function after stroke
Share on FacebookShare on TwitterShare on LinkedIn

1. The rate of acute ischemic stroke was elevated in South Asian males recovering from asymptomatic SARS-CoV-2 2019 (COVID-19) infection.

Evidence Rating Level: 4 (Below Average)

Study Rundown: There is growing evidence to suggest that acute SARS-CoV-2 (COVID-19) infections may increase the risk of acute ischemic stroke (AIS). However, AIS in asymptomatic COVID-19-infected individuals recovering from the virus has yet to be investigated. This case series explored the incidence of AIS during the post-COVID-19 infection phase in asymptomatic adults 50 years or younger. 18 patients were diagnosed with AIS among the 54 485 individuals who tested positive for COVID-19 by serological testing during the study period. The calculated annual incidence rate of AIS was significantly higher in this cohort compared to the rate of an age-, sex-, and ethnicity-matched group from national data. None of the patients demonstrated evidence of respiratory disease through clinical and radiological assessment, and all survived during AIS hospitalization. These findings imply an increased risk of AIS cases in asymptomatic males post-COVID-19-infection. One limitation of this case series study, however, was that it examined only males in only one region with a very limited sample size. A larger, multi-centre prospective cohort study would be appropriate to better assess the risk of AIS in asymptomatic individuals post-COVID-19-infection.

Click to read the study in JAMA Network Open

Relevant Reading: Risk of ischemic stroke in patients with coronavirus disease 2019 (COVID-19) vs patients with influenza

In-Depth [case series]: This case series prospectively included South Asian adult males (50 years or younger) who worked in Singapore and lived in dormitories from May 21, 2020 to October 14, 2020 (21 weeks). The 54 485 people who tested positive for SARS-CoV-2 serological (antibodies) tests were considered the population at risk. The primary outcome was the incidence of AIS cases compared to an age-, sex-, and ethnicity-matched cohort. 18 patients (median [range], 41 [35-50] years) presented with AIC, and the median (range) time from positive serological test to AIS presentation was 54.5 (0-130) days. Large vessel occlusion was found on imaging in 10/18 patients (56%). Annual Incidence rates of AIS were significantly higher in this cohort (82.36 cases per 100 000 people) compared to the incidence rate of an age-, sex-, and ethnicity-matched group from national data (38.2 cases per 100 000 people) (rate ratio, 2.16; 95% CI: 1.36-3.48; p< 0.001).

RELATED REPORTS

Apixaban (Eliquis) is associated with reduced rates of ischemic stroke and bleeding in patients with atrial fibrillation and advanced chronic kidney disease compared with warfarin (Coumadin)

Thrombectomy may improve functional independence in acute ischemic stroke with medium vessel occlusion

2 Minute Medicine Rewind April 20, 2026

Image: PD

©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: ischemic stroke
Previous Post

Novel cardiovascular biomarkers associated with modest discrimination in early, noninvasive diagnosis of type 2 myocardial infarction

Next Post

Social vulnerability influences coronavirus disease 2019 outcomes in major cities

RelatedReports

Nephrology

Apixaban (Eliquis) is associated with reduced rates of ischemic stroke and bleeding in patients with atrial fibrillation and advanced chronic kidney disease compared with warfarin (Coumadin)

September 9, 2026
No obesity paradox found between BMI, stroke, and death
Neurology

Thrombectomy may improve functional independence in acute ischemic stroke with medium vessel occlusion

May 26, 2026
Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults
Weekly Rewinds

2 Minute Medicine Rewind April 20, 2026

April 20, 2026
Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults
Chronic Disease

Virtual reality rehabilitation is safe and feasible for upper extremity recovery after subacute ischemic stroke

February 25, 2026
Next Post
Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children

Social vulnerability influences coronavirus disease 2019 outcomes in major cities

Medical vaccine exemptions increase after elimination of nonmedical exemptions

Nationwide mass vaccination highly effective against coronavirus disease 2019

Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children

Hydroxychloroquine and lopinavir-ritonavir not effective against SARS-CoV-2

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Children with intellectual and developmental disabilities have increased risks of depression and anxiety
  • Gabapentin (Neurontin) prescription for chronic low back pain in adults is associated with a higher risk of dementia
  • The rate of urethrocutaneous fistula formation may be similar between caudal and penile blocks
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.